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We explored the relationship of obesity and inflam-
matory arthritis (IA) by selectively expressing diph-
theria toxin in adipose tissue yielding ‘‘fat-free’’
(FF) mice completely lacking white and brown fat.
FF mice exhibit systemic neutrophilia and elevated
serum acute phase proteins suggesting a predispo-
sition to severe IA. Surprisingly, FFmice are resistant
to K/BxN serum-induced IA and attendant bone
destruction. Despite robust systemic basal neutro-
philia, neutrophil infiltration into joints of FF mice
does not occur when challenged with K/BxN serum.
Absence of adiponectin, leptin, or both has no effect
on joint disease, but deletion of the adipokine adip-
sin (complement factor D) completely prevents
serum-induced IA. Confirming that fat-expressed
adipsin modulates the disorder, transplantation of
wild-type (WT) adipose tissue into FF mice restores
susceptibility to IA, whereas recipients of adipsin-
deficient fat remain resistant. Thus, adipose tissue
regulates development of IA through a pathway in
which adipocytes modify neutrophil responses in
distant tissues by producing adipsin.
INTRODUCTION
Inflammatory arthritis (IA) is a family of chronic immune diseases
characterized by production of proinflammatory cytokines,
immune cell infiltration into joints, and pathologic remodeling
of bone and cartilage (Deng and Lenardo, 2006). Neutrophils
are abundant in synovial fluid of RA patients and participate in
development of the disease (Cross et al., 2005; Dominical
et al., 2011).
Adipose tissue, long viewed as exclusively responsible for en-
ergy storage and structural stability, is now considered an endo-
crine organ that stores and secretes hormones and cytokines
(adipokines) (Kershaw and Flier, 2004). Although the relationship
of adipose tissue to IA is poorly defined, circulating adipokines,
including leptin, adiponectin, and visfatin, are increased in
arthritic patients (Otero et al., 2006; Yoshino et al., 2011). Adipsin,
also known as complement factor D (FD), is abundant and exclu-
sively expressed in adipose tissue, but its relevance, and that of
fat, to inflammatory joint disease is enigmatic (White et al., 1992).
To explore this issue, we generated ‘‘fat-free’’ (FF) mice that
lack all white and brown adipose tissues, although marrow adi-
pocytes are preserved (Wu et al., 2018). As such, circulating adi-
pokines are virtually undetectable. We then used the serum
transfer K/BxN model of IA, which mirrors the effector phase of
rheumatoid arthritis (RA), to investigate the role of adipose tissue
in joint disease (Christensen et al., 2016; Misharin et al., 2014).
Although FF mice have abundant neutrophils in blood, spleen,
and peritoneal cavity, in steady state, they are completely pro-
tected from K/BxN serum transfer arthritis. Moreover, genetic
deletion and fat transplantation experiments establish that adip-
sin, but neither adiponectin nor leptin, is required for develop-
ment of IA. These data show that adipose tissue regulates
immune diseases in the joints and identifies adipsin as a major
link between adipose tissue and IA.
RESULTS
FF Mice Exhibit Systemic Neutrophilia
Given the essential role of neutrophils in the progress of murine
(Wipke andAllen, 2001) and human (Cross et al., 2005; Dominical
et al., 2011) IA, we first measured their abundance in three sys-
temic compartments in FF mice. The percentage of neutrophils
comprising CD45+ immune cells is significantly increased in FF
mice, as are their numbers in blood, spleen, and peritoneal cavity
(PEC) lavage (Figure 1). Serum acute phase proteins (APPs),
including haptoglobin, C-reactive protein, a-1-acid glycoprotein,
and a-macroglobulin, are indicative of acute phase inflammatory
markers in IA patients and are enhanced (Table S1) (Cylwik et al.,
2010).
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FF Mice Are Refractory to IA
The hyperinflammatory state of FF mice suggests that they are
prone to IA. To determine if this is so, we used the K/BxN serum
transfer-induced model of the effector phase of RA (Kouskoff
et al., 1996). Transfer of serum from arthritic K/BxN mice into
Cremice induces profound paw and ankle swelling, appearing
within 48 h and maximizing at day 4 (Figures 2A–2C). Contrary to
our prediction of hypersensitivity, however, injection of K/BxN
serum failed to increase joint thickness in FF mice (Figures 2A–
2C). Micro-computed tomographic (mCT) imaging reveals exten-
sive bone erosion in the ankles of Cre serum-injected mice,
while those lacking fat are essentially spared (Figure 2D).
Histological analysis demonstrates massive infiltration of syno-
vial space by inflammatory cells, bone and cartilage destruction,
and an abundance of tartrate-resistant acid phosphatase
(TRAP)-expressing osteoclasts in joints of Cre but not FF
mice (Figures 2E and 2F). Consistent with these observations,
serum-injected FF mice exhibit no evidence of synovial immune
cell infiltration (Figures 2G and 2H). The majority (80%–85%) of
the infiltrating cells in Cre mice are neutrophils (Figure 2I),
and the relative magnitude of their increase following serum
injection mirrors that of total immune cells (Figures 2I and 2J).
Synovial macrophages and monocytes are also dramatically
induced only in Cre mice when serum challenged (Figures 2K
and 2L). Interleukin 1 b (IL1b), which is expressed by neutrophils
and promotes their migration (Guma et al., 2009; Kay and Cal-
abrese, 2004; Rider et al., 2011), is robustly increased in the
joints of serum-injected Cre but not FF mice (Figure 2M).
Thus, complete lipoatrophy prevents IA despite substantial sys-
temic innate inflammation.
Adiponectin and/or Leptin Deficiency Does Not Affect IA
Although FF mice have virtually no circulating adipokines, adi-
ponectin and leptin are increased in patients with RA (Otero
et al., 2006; Yoshino et al., 2011). Adiponectin is a particularly
relevant candidate to influence RA because it is the most
abundant adipokine in synovial fluid (Scha¨ffler et al., 2003). It
induces matrix metalloproteinase and proinflammatory cyto-
kine expression by joint-resident immune cells (Frommer
et al., 2010).
To determine if IA is dependent on adiponectin, we injected
K/BxN serum into wild-type (WT) or adiponectin-knockout (KO)
mice. Surprisingly, WT and adiponectin-KOmice exhibit similarly
severe limb swelling, joint bone erosion, joint inflammation, and
osteoclast induction (Figures S1A–S1E). Thus, serum-induced IA
is independent of adiponectin.
We performed similar experiments to determine if the
absence of leptin mediates the joint-protective effect of fat
depletion. Leptin-KO mice develop serum transfer-induced IA
in a manner mirroring controls, as characterized by similar
paw and ankle swelling, bone erosion, joint inflammation, and
osteoclast induction (Figures S1F–S1J). These data indicate
that neither isolated adiponectin nor leptin deficiency affects
serum transfer-induced IA. To determine if their combined
absence, as occurs in FF mice, may influence joint destruction,
we administered serum to mice lacking both adiponectin and
leptin (DKO). Like their single gene-deficient counterparts, dou-
ble KO (DKO) mice develop IA in a manner identical to WT con-
trols (Figures S1K–S1O). Thus, neither adiponectin nor leptin,
alone or in combination, is involved in the pathogenesis of
serum transfer IA.
Adipsin-KO Mice Are Resistant to IA
Adipsin, also known as complement factor D, is a secreted
serine protease derived almost exclusively from adipose tissue
and is diminished in obesity (Flier et al., 1987; Lowell et al.,
1990; Wu et al., 2018). Adipsin is an essential component of
the alternative complement pathway and therefore may also
regulate innate immune responses in the joint. Mirroring FF
mice and unlike those lacking adiponectin and/or leptin, injection
of K/BxN serum into adipsin-deficient mice produces no paw
and ankle swelling, periarticular bone erosion, osteoclast induc-
tion, or recruitment of innate immune cells such as neutrophils,
macrophages, and monocytes into synovial fluid (Figures 3A–
3L). In keeping with their resistance to IA, Il1b mRNA is reduced
in the joints and synovial fluid of serum-injected, adipsin-
deficient mice (Figure 3M). Expression of adipsin by fat therefore
appears central to the development of IA. To confirm this hypoth-
esis, we transplanted white adipose tissue, obtained from WT
or adipsin-KO mice, into FF mice. Six weeks after fat
Figure 1. FF Mice Exhibit Systemic Neutrophilia
Frequencies and numbers of neutrophils in (A and B) blood, (C and D) spleen,
and (E and F) peritoneal cavity (PEC) of FF mice. Two-way ANOVA with Tukey
post hoc testing; mean ± SD; n = 5 mice; *p < 0.05 and ***p < 0.001.
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transplantation, we administered K/BxN serum to recipient mice.
Nine days later, adipsin is evident in serum of FF mice trans-
planted with WT adipose tissue, although less than that of
Cre controls (Figure 4A). In contrast, the cytokine is undetect-
able inmice graftedwith adipsin-KO fat. Confirming the essential
role of adipose tissue in the pathogenesis of IA,WT fat transplan-
tation substantially normalizes the susceptibility of FF mice to
serum-induced ankle and paw swelling (Figures 4B and 4C).
Alternatively, adipsin-deficient fat transplanted into FF mice in-
duces only a slight increase of paw swelling and does not affect
ankle thickness (Figures 4B and 4C). Further confirming that fat-
derived adipsin is essential for the development of IA, WT but not
adipsin-KO fat transplantation restores the ability of K/BxN
serum to induce bone erosion and increase inflammation and
osteoclast number in FF mice (Figures 4D–4F).
DISCUSSION
Obesity, originally considered exclusively ametabolic disease, is
an inflammatory condition characterized by immune cell activa-
tion and increased expression of proinflammatory cytokines that
drive both innate and adaptive immunity. In particular, obesity is
associated with a type 1 inflammatory response as well as acti-
vation of the IL-17A/neutrophil immune axis, resulting in system-
ically increased neutrophils in obese mice and humans (Johnson
et al., 2012). A reasonable hypothesis holds, therefore, that
obesity likely predisposes to and accelerates progression of
IA. Although it appears that obese patients are more susceptible
to IA, it is perplexing that progression of the disease may be
slower than in affected, lean individuals (Baker et al., 2014; van
der Helm-van Mil et al., 2008).
Various adipokines have been linked to IA. For example, there
is experimental evidence that targeting visfatin, which is
modestly increased in obesity, promotes joint inflammation (Go´-
mez et al., 2011a). However, the role of the two most abundant
cytokines, leptin and adiponectin, is unclear (Otero et al., 2006;
Yoshino et al., 2011). Leptin, which increases in the circulation
with obesity, is postulated to aggravate IA (Toussirot et al.,
2015). Complicating our understanding of leptin’s role in IA, its
circulating abundance correlates inversely with IA joint damage
(Go´mez et al., 2011b; Rho et al., 2009; Tong et al., 2008). Simi-
larly, adiponectin, which is reduced in obesity, promotes IL-6
and MMP-1 expression by synovial fibroblasts (Ehling et al.,
2006) and is predictive of radiographic RA progression (Klein-
Wieringa et al., 2011). Yet administration of adiponectin reduces
the severity of collagen-induced arthritis in mice (Ebina et al.,
2009). Thus, despite the endemic nature of obesity and the
frequency of IA, the impact, if any, of adipose tissue and its prod-
ucts on the pathogenesis of IA is enigmatic.
Given this conundrum, we asked if the absence of fat, at-
tended by a virtual lack of adipokines, modulates IA. We find
that FFmice are completely protected from IA in face of systemic
neutrophilia and increased circulating biochemical indicators of
acute phase proteins. Thus, induction of IA may be independent
of the systemic inflammation of obesity or lipodystrophy. The
complete resistance of FF mice to serum-induced joint inflam-
mation and destruction, and particularly its reversal by WT fat
transplantation, indicates that adipose tissue, per se, modulates
inflammatory disease in joints. The virtual absence of adipokines
in these animals also provided the opportunity to determine the
influence of depletion of specific adipocyte products on this fam-
ily of disorders. Indicating that absence of leptin and/or adipo-
nectin is likely not responsible for the resistance of fat-deficient
animals to serum transfer arthritis, the joints of injected mice
lacking either adipokine, alone or in combination, are inflamed
and degraded to the same extent as control. On the other
hand, our findings indicate that adipose tissue has a critical
role in the pathogenesis of the effector phase of inflammatory
joint destruction by producing adipsin, an adipokine that is
decreased in obesemice and humans. This conclusion is consis-
tent with the resistance of mice with genetically induced obesity
and a paucity of adipsin, to IA (Busso et al., 2001; Flier et al.,
1987)
Complement activation commonly occurs in arthritic joints
(Struglics et al., 2016). Moreover, the alternative complement
pathway is central to development of both collagen-induced
and serum transfer arthritis and likely contributes to the progres-
sion of human RA through generation of C3 convertases (Banda
et al., 2006; Ji et al., 2002). Although C5a, C3, and factor B are
established mediators of this arthritic state, the role of adipsin
has not been explored. Because adipsin is the only complement
component almost exclusively produced by adipose tissue in
mice, it represents a possible link between obesity, lipodystro-
phy, and IA, particularly as circulating levels of this adipokine
fall dramatically with weight gain (Cook et al., 1987; Flier et al.,
1987). Furthermore, like that lacking adipsin, a mouse devoid
of fat is incapable of complement activation via the alternative
pathway (Wu et al., 2018). Thus, the alternative pathway func-
tions as a powerful feedback loop. It is involved in the pathogen-
esis of many diseases, making it an attractive therapeutic
candidate. In keeping with our findings, induction of joint inflam-
mation in serum transfer arthritis depends on C3 (Ji et al., 2002)
Figure 2. FF Mice Are Protected from Serum Transfer Arthritis
FF and Cre mice were injected with K/BxN serum on days 0 and 3.
(A) Hind paws of Cre and FF mice 9 days after initial serum injection.
(B and C) Ankle (B) and paw (C) thickness measured over time.
(D) mCT image of rear ankle of Cre and FF mice 9 days after initial serum injection.
(E) Histological image of rear ankle of Cre and FF mice 9 days after initial serum injection stained for TRAP activity (red reaction product).
(F) TRAP-stained area as a function of total area (scale bar, 2.5 mm).
(G and H) Frequency (G) and number (H) of total immune cells in synovial fluid of Cre and FF mice 7 days after initial serum or PBS injection.
(I and J) Frequency (I) and number (J) of neutrophils in synovial fluid of Cre or FF mice 7 days after initial serum or PBS injection.
(K and L) Numbers of (K) macrophages and (L) monocytes in synovial fluid of Cre and FF mice 7 days after initial serum or PBS injection.
(M) IL-1b mRNA expression in joints and synovial fluid of Cre and FF mice 7 days after initial serum or PBS injection.
In (A)–(F), Student’s t test. In (I)–(M), two-way ANOVA with Tukey post hoc testing; n = 4 or 5 mice; *p < 0.05, **p < 0.01, and ***p < 0.001.
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Figure 3. Adipsin Is Required for Development of Serum Transfer IA
Adipsin-KO and WT mice were injected with K/BxN serum on days 0 and 3.
(A) Hind paws of WT and adipsin-KO mice 9 days after initial serum injection.
(B and C) Ankle (B) and paw (C) thickness measured with time.
(legend continued on next page)
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and properdin (Kimura et al., 2010). Our results therefore add
another alternative complement component, adipsin, to the list
of IA-mediating molecules.
We used the K/BxN serum transfer arthritis model because of
its convenience and speed of induction. This model and collagen
antibody-induced arthritis (CAIA) are limited, however, by their
(D) mCT image of hind paws of WT and adipsin-KO mice 9 days after initial serum injection.
(E) Histological image of rear ankle joints of WT and adipsin-KO mice 9 days after initial serum injection stained for TRAP activity (red reaction product).
(F) TRAP-stained area/total area; scale bar, 2.5 mm.
(G and H) Frequencies (G) and numbers (H) of immune cells in synovial fluid of adipsin-KO mice 7 days after initial serum or PBS injection.
(I and J) Frequencies (I) and numbers (J) of neutrophils in synovial fluid of adipsin-KO mice 7 days after initial serum or PBS injection.
(K and L) Numbers of (K) macrophages and (L) monocytes in synovial fluid of adipsin-KO mice 7 days after initial serum or PBS injection.
(M) IL-1b mRNA expression in joints and synovial fluid of WT and adipsin-KO mice 7 days after initial serum or PBS injection.
In (A)–(F), Student’s t test. In (I)–(M), two-way ANOVA with Tukey post hoc testing; n = 4 or 5 mice; *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 4. Fat-Residing Adipsin Promotes IA
FF mice were transplanted, subcutaneously, with white adipose tissue obtained from WT or adipsin-KO mice. FF mice subjected to sham surgery served as
control. Six weeks after fat transplantation, mice were injected with serum on days 0 and 3. At day 9, mice were sacrificed and serum was collected.
(A) Adipsin, in increasing amounts of serum, detected by immunoblot in Cre mice, sham-operated FF mice, FF mice transplanted with WT fat, and FF mouse
transplanted with adipsin-KO fat.
(B and C) Ankle (B) and paw (C) thickness measured with time.
(D) mCT image of hind paws of control, sham-operated, and fat-transplanted mice 9 days after initial serum injection.
(E and F) Histological image of rear ankle joints of control, sham-operated, and fat-transplanted mice 9 days after initial serum injection stained for TRAP activity
(red reaction product) (E) and TRAP-stained area/total area (F) of (E). Scale bar, 500 mm.
Two-way ANOVAwith Tukey post hoc testing; n = 3–5mice; *p < 0.05, **p < 0.01, ***p < 0.01, and ****p < 0.01 indicateWT-fat > FF comparedwith sham; #p < 0.05
indicates adipsin-fat > FF compared with sham.
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mirroring only the effector phase of RA. Thus, future studies war-
rant testing the effects of fat depletion on the collagen II-induced
arthritis (CIA) model, which represents both the priming and
effector phases of RA. Given that CIA is ameliorated by comple-
ment deficiency, it is likely to be dampened by fat depletion (Hie-
tala et al., 2002).
Progression of IA is characterized by immune cell migration into
joints. Neutrophils are abundant in synovial fluid of patients with
active RA and mediate its progression (Cross et al., 2005; Domin-
icaletal., 2011).Nevertheless, themechanismofneutrophil infiltra-
tion into joints in IA is unclear. Complement activation promotes
neutrophil adhesion toendothelial cells,while it is reducedbycom-
plement blockade (Riedl et al., 2016). Indeed, our data show that
adipsin depletion prevents neutrophil accumulation into IA joints,
indicating fat regulates neutrophils via an adipsin-dependent
pathway.Activatedneutrophils also trigger the alternative comple-
ment pathway (Camouset al., 2011), suggesting that crosstalk be-
tweenneutrophils andadipsin-dependent complement activation.
Because adipsin is a relatively small protein (molecular weight
25 kDa) and is required for efficient alternative pathway activa-
tion and amplification, it is an attractive target for pharmaceutical
intervention. Manymonoclonal anti-adipsin antibodies as well as
small molecules have been developed to block the adipokine (Le
et al., 2015). The goal is to treat human diseases such as age-
related macular degeneration, paroxysmal nocturnal hemoglo-
binuria, atypical hemolytic uremic syndrome, and other diseases
that may be mediated by alternative complement pathway acti-
vation. Of note, adipsin-KO mice grow and develop normally
(Xu et al., 2001). Also, in standard animal husbandry conditions,
they require challenge with certain infectious agents to bring out
their immune deficit. However, the positive effect of adipsin on b
cell function in diabetes challenges this conclusion and indicates
that direct suppression of joint-residing adipsin may be neces-
sary (Lo et al., 2014).
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KEY RESOURCES TABLE
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Steven L.
Teitelbaum (teitelbs@wustl.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
FF mice were generated by cross-mating animals expressing diphtheria toxin (DTA) containing a flox-STOP-flox cassette to those
expressing Cre under control of the adiponectin promoter (Wu et al., 2018). Cre-littermates (Cre-) served as control in all experiments
involving FF mice. Since FF mice die at birth at room temperature, they were housed at 30C and maintained at 22C in a 12-h light-
dark cycle when studied. All other mice were kept at 22C in a 12-h light-dark cycle. Adipsin-KOmice have been described (Xu et al.,
2001). Adiponectin-KO mice and leptin-KO mice were obtained from Jackson laboratory and mated to generate adiponectin-leptin
double-KO (DKO) mice. WT mice served as control for experiments involving adiponectin and leptin knockout mice. KRN mice were
kindly provided by Dr. Christophe Benoist, Harvard Medical School. NOD mice were obtained from Jackson laboratory. The first
generation of KRN mice X NOD mice are K/BxN mice and spontaneously develop arthritis. Their serum was collected and stored
at 80C. FF mice, adipsin-KO mice and adiponectin-KO mice are 6-9 weeks old. Leptin-KO mice and DKO mice are studied at
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat-anti-monoclonal adipsin antibody R&D systems Cat# MAB5430; RRID:AB_210837
FcBlock BD Biosciences clone 24G.2; RRID:AB_394656
Rat anti-mouse CD45-BUV395 BD Horizon clone 30-F11; RRID:AB_2651134
Rat anti-mouse Ly6G-PE/Cy7 BioLegend clone 1A8; RRID:AB_1877262
Rat anti-mouse/human CD11b-BV650 BioLegend clone M1/70; RRID:AB_11125575
Rat anti-mouse Ly6C-FITC BioLegend clone HK1.4; RRID:AB_1186134
Mouse anti-mouse CD64-PE-Dazzle594 BioLegend clone X54-5/7.1; RRID:AB_2566558
Rat anti-mouse F4/80-APC BioLegend clone BM8; RRID:AB_893493
IL1b Forward primer (GTGCAAGTGTCTGAAGCAGC) Integrated DNA Technologies N/A
IL1b Reverse primer (CAAAGGTTTGGAAGCAGCCC) Integrated DNA Technologies N/A
GAPDH Forward primer (TTCGACAGTCAGCCGCATCTTCTT) Integrated DNA Technologies N/A
GAPDH Reverse primer (CAGGCGCCCAATACGACCAAATC) Integrated DNA Technologies N/A
Chemicals, Peptides, and Recombinant Proteins
Zombie UV BioLegend Cat #423108
Critical Commercial Assays
iScript TM cDNA synthesis kit Bio-RAD Cat #170-8891
Powerup TM SYBR TM Green Thermo Fisher Scientific Cat #25742
Experimental Models: Organisms/Strains
Fat free mice Wu et al., 2018 N/A
Adipsin-KO mice Wu et al., 2018 N/A
C57BL/6 mice The Jackson Laboratory Stock No: 000664
Adiponectin-KO mice The Jackson Laboratory Stock No: 008195
Leptin-KO The Jackson Laboratory Stock No: 000632
Adiponectin-leptin double KO mice N/A N/A
KRN mice From Dr. Christophe Benoist N/A
NOD mice The Jackson Laboratory Stock No: 001976
Software and Algorithms
GraphPad Prism 7 GraphPad https://www.graphpad.com/
Bioquant Osteo V7 10.10 Bioquant https://bioquant.com/
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the age of 3 weeks because of joint swelling with obesity. Animal experiments were performed according to the policies of Animal
Studies Committee (ASC) at Washington University School of Medicine in St. Louis. Mice were analyzed by approved protocols and




Six-week-old male C57BL/6 mice served as donors. Fat pads were removed from the inguinal or the intra-abdominal perigonadal
(epididymal) region after donor mice were euthanized with CO2. Recipient mice were anesthetized by isoflurane. Fat pads of 1.5
donor mice were transplanted into the dorsal subcutaneous area of recipient mice. All recipient mice are on a C57BL/6 background.
Isolation of immune cells and flow cytometry
Synovial fluid was collected by washing the synovial cavity with 1 mL PBS. Collected immune cells were subjected to centrifugation
at 500 x g at 4C for 5 min and stained with the dead cell exclusion dye ZombieUV (1:600; BioLegend) in 50 mL PBS. Cells were incu-
bated with 10 mg/mL FcBlock (clone 24G.2; BD Biosciences) in PBS containing 2.5% heat-inactivated fetal bovine serum (FBS) and
2mMEDTA before being stained for flow cytometric analyses, as previously described (Rohatgi et al., 2018). The following antibodies
were used: rat anti-mouse CD45-BUV395 (BD Horizon; clone 30-F11; 1:200), rat anti-mouse Ly6G-PE/Cy7 (BioLegend; clone 1A8;
1:300), rat anti-mouse/human CD11b-BV650 (BioLegend; clone M1/70; 1:400), rat anti-mouse Ly6C-FITC (BioLegend; clone HK1.4;
1:400), mouse anti-mouse CD64-PE-Dazzle594 (BioLegend; clone X54-5/7.1; 1:300), and rat anti-mouse F4/80-APC (BioLegend;
clone BM8; 1:300). Flow cytometric analyses were performedwith FlowJo (version 10, Ashland, OR), and cells were gated on singlets
and live cells. Bulk immune cells were defined as CD45+ cells. Neutrophils were defined as CD45+ CD11b+ Ly6G+ cells. Monocytes
were defined as CD45+ CD11b+ Ly6G– Ly6Chi cells. Macrophages were defined as CD45+ CD11b+ Ly6G– Ly6C– F4/80+ cells.
Immunoblot
After denaturing in sodium dodecyl sulfate (SDS), serum was subjected to 10% SDS–polyacrylamide gel electrophoresis and trans-
ferred to polyvinylidene difluoride transfer membranes. The membranes were blocked with 0.1% casein in PBS and incubated with
primary Rat-anti-monoclonal adipsin antibody (R&D systems, Minneapolis, MN) at 4C overnight followed by probing with fluores-
cence-labeled secondary antibody. Proteins were visualized with the Odyssey infrared imaging system (LI-COR Biosciences).
Serum Transfer Arthritis
K/BxN serum (200 ml) were injected i.p. into recipient mice at days 0 and 3. The mice were monitored daily for the development of
arthritis. PBS injection served as control. Paw and ankle thicknessweremeasuredwith digital calipers. On day 9, bloodwas collected
prior to mice being anesthetized for dissection.
Histology
Nine days after injection of K/BxN serum, animals were sacrificed and paws removed and fixed in 10% neutral buffered formalin for
24 h and rinsed in water before bones were decalcified in 14% EDTA (pH 7.2) for 20 days. Histological sections were stained with
hematoxylin & eosin (H&E) and tartrate-resistant acid phosphatase (TRAP). The stained sections were scanned with Nanozoomer.
To quantitate the TRAPpositive area in the boxed region of interest (ROI), we usedBioquant Osteo V7 10.10 (Bioquant Image Analysis
Corp., Nashville, TN).
Micro-computed tomography (mCT)
Bone structure of rear paws was assessed using a Scanco mCT40 scanner (ScancoMedical AG, Bassersdorf, Switzerland). Because
of variation of bone mineral density with age, a threshold of 450 was used to evaluate scans of fat transplanted mice, and a threshold
of 320 for all other mice.
RNA extraction and qPCR
Total RNA of soft tissue and fluid in synovial joints was extracted with TRIzol. Complementary (c)DNA was synthesized from RNA
(1 mg) using the iScript cDNA Reverse Transcription kit (Bio-Rad) according to the manufacturer’s instructions. Real-time PCR
was performed using the SYBR Green Master Mix kit and the gene-specific primers were listed in STAR METHOD. Quantitative
PCR was performed on ABI PRISM 7500 sequence detection system (Applied Biosystems, Foster City, CA). Gene expression
was calculated using the DDCT method.
Acute phase proteins (APP) assay
The serum concentrations of APP in FF mice were detected by EVE Technologies. Briefly, haptoglobin, C-reactive protein, a-1-acid
glycoprotein and a-macroglobulin in serum of FF mice were measured with Discovery Assay.
e2 Cell Reports 27, 2809–2816.e1–e3, June 4, 2019
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as means ± standard deviation (SD). Differences between groups were evaluated by unpaired Student’s t test or
two-way analysis of variance (ANOVA) with Tukey post hoc testing as recommended by Prism (GraphPad La Jolla, CA). The details
were indicated in figure legends. P values are indicated when differences between two groups were statistically significant (< 0.05).
Analyses were performed in Excel and Prism 7.
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 Supplemental Figure S1, related to Figure 3.  Serum transfer IA is independent of adiponectin and/or leptin. (A-
E) Adipo-KO, (F-J) leptin-KO, (K-P) DKO and (A-PO) WT mice were injected with serum on day 0 and 3. (A,F,K) 
Ankle and (B,G,M) Paw thickness was measured with time. Nine days after initial serum injection (C,H,N) µCT image 
of hind paws was obtained, (D,I,O) histological image of rear ankle joints stained for TRAP activity and (E,J,P) TRAP 
stained area/total area (red reaction product) were determined, Scale bar=2.5 mm. Student’s t-test, n=4-5 mice.  
 
Cre- FF P 
  Serum amyloid P   321±44 µg/ml   322±35 µg/ml NS 
  Haptoglobin   24.1±12.6 µg/ml   508±247 µg/ml 0.028 
C-reactive protein   9.51±0.16 µg/ml   28.3±5.0 µg/ml 0.003 
  Acid glycoprotein   196±22 µg/ml   295±25 µg/ml 0.007 
  Alpha-macrolobulin   2.76±0.35 mg/ml   4.36±0.306 mg/ml 0.004 
Supplemental Table S1, related to Figure 1. Serum concentrations of acute phase proteins in FF mice. Student’s t-
test, n=3 mice, P-values are indicated in the table.  
